Drug reference

Magnesium trisilicate

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 97

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Dyspepsia ▶BY MOUTH USING CHEWABLE TABLETS ▶Adult: 1–2 tablets as required

PDF page 97

Contra Indications

Hypophosphataemia

PDF page 97

Safety

Interactions

→Appendix 1: antacids

PDF page 97

Side Effects

Diarrhoea. nephrolithiasis (long term use)

PDF page 97

Hepatic Impairment

Avoid in hepatic coma; risk of renal failure.

PDF page 97

Renal Impairment

Dose adjustments Avoid or used at a reduced dose (increased risk of toxicity).

PDF page 97

Dose and formulations

Medicinal Forms

No licensed medicines listed.

PDF page 97

Dose text by age group

Adult

1–2 tablets as required

First-line fragment. Read the complete Indications and Dose section above.

PDF page 97

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Magnesium trisilicate

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 97

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Dyspepsia ▶BY MOUTH USING CHEWABLE TABLETS ▶Adult: 1–2 tablets as required

PDF page 97

Contra Indications

Hypophosphataemia

PDF page 97

Safety

Interactions

→Appendix 1: antacids

PDF page 97

Side Effects

Diarrhoea. nephrolithiasis (long term use)

PDF page 97

Hepatic Impairment

Avoid in hepatic coma; risk of renal failure.

PDF page 97

Renal Impairment

Dose adjustments Avoid or used at a reduced dose (increased risk of toxicity).

PDF page 97

Dose and formulations

Medicinal Forms

No licensed medicines listed.

PDF page 97

Dose text by age group

Adult

1–2 tablets as required

First-line fragment. Read the complete Indications and Dose section above.

PDF page 97

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.